US Stocks
/
MaxCyte, Inc. Share Price

MaxCyte, Inc. Share Price

NASDAQ: MXCT | Micro Cap
$1.01
-$0.01 (-0.98%) Last updated on 10 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

MaxCyte, Inc. Stock Performance

Open
$1.02
Prev. Close
$1.02
Circuit Range
N/A
Day Range
$0.99 - $1.02
Year Range
$0.65 - $1.86
Volume
3,826
Average Traded
$1.01

MaxCyte, Inc. Share Price Today

As of 10 October 2026, MaxCyte, Inc.'s share price is $1.01. The stock opened at $1.02, compared to its previous close of $1.02. During today's trading session, MaxCyte, Inc.'s share price traded between $0.99 and $1.02, with an average price of $1.01. Over the past 52 weeks, the stock has recorded a high of $1.86 and a low of $0.65. In terms of performance, MaxCyte, Inc.'s share price has risen by 14.90% over the last six months and is down 34.20% on a year-on-year basis.

MaxCyte, Inc. Share Price Chart

$0.99$1.02
L
Show Current Price
H

MaxCyte, Inc. Stock Fundamentals & Key Indicators

Market Cap
$107.49M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.35
Revenue (TTM)
$33.03B
Return On Equity (TTM)
-22.45%
Profit Margin
-135.12%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
28.58%

MaxCyte, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$6.83$7.30$9.65$7.27
Net Profit-$12.42-$9.60-$4.75-$8.87
Net Profit Margin-181.84%-131.51%-49.22%-122.01%
Income ChangeN/A22.71%50.52%-86.74%

MaxCyte, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$44.26$41.29$38.63$33.03
Net Profit-$23.57-$37.92-$41.06-$44.63
Net Profit Margin-53.25%-91.84%-106.29%-135.12%
Income ChangeN/A-60.88%-8.28%-8.69%

About MaxCyte, Inc.

MaxCyte Inc is a life sciences company focused on advancing the discovery, development, and commercialization of next-generation cell therapies. It uses its proprietary cell engineering technology platform to support biotechnology and pharmaceutical customers in cell therapy, gene editing, immuno-oncology, and biologic development. It operates in one segment: cell engineering technology, which generates revenue mainly from product sales, licenses, research and clinical license fees, and program-related revenues as its SPL customers achieve development and regulatory milestones. Its platform, the ExPERT Platform, is based on Flow Electroporation technology designed to efficiently and safely modify human cells with high efficiency, low cytotoxicity, and scalability for clinical use.

MaxCyte, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$1.14
$1.02
-9.33%
Sep 2026
$1.26
$1.13
-12.11%
Aug 2026
$1.06
$1.28
+21.33%
Jul 2026
$1.24
$1.05
-14.23%
Jun 2026
$1.20
$1.23
+1.65%
May 2026
$0.86
$1.21
+37.66%
Apr 2026
$0.70
$0.88
+24.86%
Mar 2026
$0.80
$0.70
-13.19%
Feb 2026
$0.90
$0.81
-11.27%
Jan 2026
$1.55
$0.91
-40.84%
Dec 2025
$1.75
$1.54
-11.71%
Nov 2025
$1.52
$1.75
+14.01%

MXCT Share Price FAQs

What is MaxCyte, Inc. share price today?

chevron-up
MaxCyte, Inc. share price today is $1.01 as on October 10, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of MaxCyte, Inc. stock?

chevron-up
The 52 week high of MaxCyte, Inc. stock is $1.86, while the 52 week low is $0.65 as of 10 Oct '26.

What is MXCT's market capitalisation today?

chevron-up
MXCT market capitalisation is $107.49M as of October 10, 2026, at 6:48 am IST.

What is MXCT's net income for the last quarter?

chevron-up
MXCT's net income for the last quarter is -8.87B USD.

What is the 5 year returns of MXCT?

chevron-up
The 5 year returns of MXCT is -91.01% as on 10 Oct '26.

What is the high & low stock price of MXCT today?

chevron-up
MXCT stock price hit a high of $1.02 and low of $0.99 as of 10 Oct '26.

Can I buy MXCT shares in India?

chevron-up
Yes. You can buy MXCT in India by opening an international trading account.